US Patent 7423114 GD2 ligands
Patent 7423114 was granted and assigned to McGill on September, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+384 characters)
Article
Patent abstract
The invention provides ligands of ganglioside GD2, including peptide ligands such as GGITNYNSALM; YCGGITNYNSACY; YCITNYNSCY; YCGGITNYNCY; YCTNYGVHCY; YCTNYGVCY; GGIANYNTS; YCGGIANYNCY; YCGGIANYNTSCY; and, YCIANYNTCY. GD2 ligands of the invention may for example be used to treat or diagnose diseases such as cancers in which cells express GD2, including neuroblastomas.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07423114 GD2 ligands US Patent 7423114 GD2 ligands
Infobox
Patent Number
0742311400
Patent Number
742311400
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074231140
Date of Patent
September 9, 2008
0Patent Application Number
105285420
Date Filed
November 28, 2005
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074231140
Date of Patent
September 9, 2008
0Patent Application Number
105285420
Date Filed
November 28, 2005
0Official Website
Patent Primary Examiner
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07423114 GD2 ligands
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07423114
Date of patent
September 9, 2008
Patent application number
10528542
Date Filed
November 28, 2005
Patent primary examiner
Find more entities like US Patent 7423114 GD2 ligands
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
